Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06006910 · ClinicalTrials.gov registry record
Electronic Medical Record-Based Nudge to Reduce SLNB
A clinical trial of Breast Cancer and Estrogen Receptor-positive Breast Cancer, sponsored by University of Pittsburgh Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT06006910 is a study of Breast Cancer and Estrogen Receptor-positive Breast Cancer that has completed, run by University of Pittsburgh Medical Center. The registered enrollment target is 7 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06006910, a study of Breast Cancer and Estrogen Receptor-positive Breast Cancer, has completed, sponsored by University of Pittsburgh Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective, historically-controlled, quality improvement project is to determine whether and to what extent an electronic health record (EHR)-based nudge affects rates of sentinel lymph node biopsy (SLNB) in older women with ER+, early-stage, clinically node negative breast cancer.
Conditions Studied
Interventions
- BEHAVIORAL Column-based nudge in the EHR
- BEHAVIORAL No column-based nudge in the EHR
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-10-15 |
| Est. Completion | 2024-02-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06006910
The ClinicalTrials.gov registry entry for NCT06006910 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is University of Pittsburgh Medical Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Column-based nudge in the EHR is the first listed.
NCT06006910 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06006910 about?
NCT06006910 is a clinical study titled "Electronic Medical Record-Based Nudge to Reduce SLNB". The goal of this prospective, historically-controlled, quality improvement project is to determine whether and to what extent an electronic health record (EHR)-based nudge affects rates of sentinel lymph node biopsy (SLNB) in older women with ER+, early-stage, clinically node negative breast cancer.
What is the current status of trial NCT06006910?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2021-10-15. Estimated completion is 2024-02-12.
What conditions does trial NCT06006910 study?
This clinical trial studies the following conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer.
What interventions are being tested in trial NCT06006910?
The interventions under investigation include: Column-based nudge in the EHR (BEHAVIORAL), No column-based nudge in the EHR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06006910?
This trial is sponsored by University of Pittsburgh Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06006910 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Breast Cancer
All registered trials for this condition
Estrogen Receptor-positive Breast Cancer
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.